News Archive

2021

March

Media Release / Mar 17, 2021

Novartis awards $450,000 to eight nonprofit organizations through the STEP Program™

Read More

February

Media Release / Feb 16, 2021

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

Read More

January

Media Release / Jan 15, 2021

Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic idiopathic urticaria (CIU)

Read More
2020

December

Media Release / Dec 15, 2020

Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF

Read More
Media Release / Dec 09, 2020

Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer

Read More
Media Release / Dec 08, 2020

Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif®* in chronic myeloid leukemia trial

Read More
Media Release / Dec 07, 2020

Novartis and Amgen partner with Karamo Brown to support and empower people living with migraine

Read More
Media Release / Dec 01, 2020

Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps

Read More

November

Media Release / Nov 19, 2020

New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases

Read More
Media Release / Nov 13, 2020

New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17, regardless of age and gender

Read More

Related Links